Drug companies must follow the trend of the tree concept

For drug investment enterprises, it is impossible to send large numbers of personnel to market development as in the case of production-type pharmaceutical investment enterprises. Often, it is necessary to concentrate on superior strength. The promotion of pharmaceutical investment must be deepened, and each process and step must be refined; Investment promotion should highlight the execution power and implementation must be detailed. The details determine the success or failure, any one of the details of the improper operation will result in a significant reduction in the effect of investment. Drugs investment promotion pointed out that no matter whether it is telemarketing skills and skills, the team to corporate image is well displayed, the details of contracting specifications, the perfection of distributors' database, the skills of pharmaceutical investment advertisements, the budget of pharmaceutical investment, the service to dealers, etc. The key links for investment promotion are indispensable.

The pharmaceutical agent pointed out that at present, there are still many pharmaceutical investment enterprises that still stop in the previous investment promotion methods and do not seek breakthroughs. However, in the fierce competition in the pharmaceutical investment market, they want to be invincible and have a good investment strategy. It is essential. How to successfully do a good job in pharmaceutical investment is a headache for pharmaceutical investment companies. To do a good job in pharmaceutical investment needs to be gradual, and we must not be prepared to go blindly to pharmaceutical investment. This is doomed to failure.

In the view of drug merchants, if the investment enterprises do not pay attention to satisfying the needs of dealers and consumers and do not meet the needs of dealers and consumers as the starting point of the market, the fragile system of a single product cannot support the needs of the entire market. Miscellaneous and mischievous is no more than a "one can not be less," the early enthusiasm, the ultimate fate of self-talk can only be eliminated by the pharmaceutical investment market. Moreover, if the selected access mode is very good, due to the high cost of the access route, enterprises with weaker capabilities will inevitably face great difficulty in attracting investment during the specific operation process. Therefore, it is crucial to analyze and study the cost of access. Industry medicine investment experts believe that when a pharmaceutical investment enterprise adopts the pharmaceutical investment model to sell drugs, it is of utmost importance to make the investment promotion work fine. There are many details of the pharmaceutical investment promotion that require us to pay attention.

In addition, pharmaceutical investment experts believe that the pharmaceutical investment market must understand from the perspective of development, affirming that products are all from scratch, whether it is the development of science and technology is the progress of society, the emergence of new products, the operation of new market mechanisms and the competition From scratch, from weak to strong, are dynamic markets, so we have to make it clear that in the pharmaceutical sales can rely on the commonality of the product and invincible, and quickly occupy the market, after all, consumer selectivity is small, but when there are other brands The entry of similar products is tantamount to meeting competitors, and because of the lack of individuality in the products, it will appear exhausted and incapable of marketing. This requires us to analyze the reasons for the market from the perspective of development.

In the view of pharmaceutical agents, pharmaceutical investment companies can only aim for the goal to ensure that the pharmaceutical investment business receives the expected results. Many pharmaceutical investment enterprises only pay attention to the form, and there is no clear target for investment promotion and a feasible investment plan. In the fierce competition in the market, they will only follow the trend and want to be different. While improving their overall strength, they need to attract investment from the pharmaceutical industry. The company chooses a suitable differentiated marketing model. The pharmaceutical agent believes that in the premise of a good product, it is necessary to change the concept: from valuing price to value, from valuing channels to valuing terminals, paying attention to sales to paying attention to the market, paying attention to benefits, and paying attention to academics. Pharmaceutical investment from the emphasis on value to value. Consumers are not afraid to buy expensive goods, but they are afraid to buy expensive products; they do not want to buy cheap products, but want to take advantage of them. Therefore, the focus of pharmaceutical investment promotion companies is not to lower prices, but to increase value, so that the value of products is a long-term approach.

Today, the pharmaceutical market is becoming increasingly rational. Some units still hold a lucky attitude, but they do not have a good model but insist that they have advanced models in an attempt to achieve the purpose of amassing money through pharmaceutical investment. By standardizing the investment promotion process of pharmaceuticals and improving the overall quality of the industry, it is possible to effectively distinguish the excellent pharmaceutical investment enterprises and the disadvantaged pharmaceutical investment enterprises in the industry, with good products and no special products, so as to drive out those companies that are in troubled waters. Only in this way can the image of the industry be re-established, and the trust between the enterprises can be established again.

Some small and medium-sized medicine investment enterprises took products that had been eliminated, changed the packaging and put a brand, made some investment advertisements, issued several flyers, and began to invite investment in the country, often without successful model market, and no successful products. The marketing model, or the model he advocates, cannot be profitable at all, but believes that the product will be married, regardless of whether it is life or death. After operating for a period of time, the dealers discovered that the model was not good, the product was obsolete, and the market did not pay for it. At this time dealers regret it too late!